Bristol, United Kingdom

Ralph Donald Quentin Collings

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.9

ph-index = 1


Location History:

  • Bristol, GB (2023 - 2024)
  • Bristol Bristol, GB (2024)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Ralph Donald Quentin Collings: Innovator in Drug Delivery Technology

Introduction

Ralph Donald Quentin Collings is a notable inventor based in Bristol, GB. He has made significant contributions to the field of drug delivery technology, holding a total of 7 patents. His innovative designs focus on improving the efficiency and functionality of medical devices.

Latest Patents

Collings' latest patents include an attachment mechanism, module, and assembly designed for drug delivery devices. This attachment mechanism is suitable for connecting modules to cylindrical or polygonal objects. It features a housing, a gripping portion with at least one gripping ring, and an actuator that operates the gripping portion between open and clamping conditions. Another significant patent is for a drive train for a torsion-spring assisted wind-up injection device. This device includes a torsional energy storage system, a user handle, and a clutch element that maintains discrete angular positions while dampening torque peaks.

Career Highlights

Collings is currently employed at Sanofi, a global healthcare company. His work focuses on developing innovative solutions that enhance drug delivery systems. His expertise in engineering and design has led to advancements in medical technology.

Collaborations

Collings has collaborated with notable coworkers, including Michael Jugl and Stefan Blancke. Their combined efforts contribute to the innovative projects at Sanofi.

Conclusion

Ralph Donald Quentin Collings is a distinguished inventor whose work in drug delivery technology has led to multiple patents and advancements in the field. His contributions continue to shape the future of medical devices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…